Skin nerve phosphorylated [formula omitted]-synuclein deposits in Parkinson’s disease with orthostatic hypotension

To investigate phosphorylated α-synuclein (p-syn) deposits in skin nerves of Parkinson’s disease (PD) patients with neurogenic orthostatic hypotension (OH) and a PD matched group without dysautonomia. We enrolled 28 idiopathic PD patients with abnormal nigro-striatal DatScan and cardiac MIBG: (1) 14...

Full description

Saved in:
Bibliographic Details
Published inClinical neurophysiology Vol. 130; no. 1; p. e17
Main Authors Donadio, V., Incensi, A., Del Sorbo, F., Rizzo, G., Infante, R., Scaglione, C., Modugno, N., Fileccia, E., Elia, A.E., Cencini, F., Liguori, R.
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.01.2019
Online AccessGet full text

Cover

Loading…
More Information
Summary:To investigate phosphorylated α-synuclein (p-syn) deposits in skin nerves of Parkinson’s disease (PD) patients with neurogenic orthostatic hypotension (OH) and a PD matched group without dysautonomia. We enrolled 28 idiopathic PD patients with abnormal nigro-striatal DatScan and cardiac MIBG: (1) 14 of them complained of neurogenic OH (PD + OH); and (2) 14 matched patients did not complain of autonomic dysfunctions (PD-OH); 7 of them were re-evaluated over a follow-up (4 ± 2 years). Patients underwent skin biopsy in proximal (i.e. C7 paravertebral spine region) and distal (i.e. thigh and leg) sites. PD + OH showed a higher p-syn deposition than PD-OH with a widespread autonomic cholinergic and adrenergic skin nerves involvement. Over the follow-up PD-OH patients showed a marked increase in motor dysfunctions scores without autonomic symptoms and a slight increase of skin p-syn deposition but still lower than PD + OH. PD + OH showed a wide involvement of p-syn deposits in autonomic cholinergic and adrenergic skin nerves skin; (2) PD-OH showed a lower load of skin p-syn mainly restricted to adrenergic fibers of skin vessels, still persisting over a follow-up. These data supported a different pathogenesis between PD + OH and PD-OH and may help to identify a specific diagnostic trait for PD + OH patients.
ISSN:1388-2457
1872-8952
DOI:10.1016/j.clinph.2018.09.099